Orakl Oncology’s €11 Million Seed Funding Round

McDermott Will & Emery advised Orakl Oncology on the transaction.Orakl Oncology, a pioneering precision oncology company, closed a EUR 11 million seed funding round, led by…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here